natgillin/translations-raw huggingface dataset:
Frequency groupings are defined according to the following convention: Very common (≥ 1/10); Common (≥ 1/100 to < 1/10); Uncommon (≥ 1/1,000 to < 1/100); Rare (≥1/10,000 to <1/1,000); Very rare (<1/10,000); Not known (cannot be estimated from the available data). 
Skupine pogostnosti so opredeljene skladno s konvencijo: zelo pogosti (≥ 1/10), pogosti (≥ 1/100 do < 1/10), občasni (≥ 1/1.000 do < 1/100), redki (≥ 1/10.000 do < 1/1.000), zelo redki (< 1/10.000), neznana pogostnost (pogostnosti iz razpoložljivih podatkov ni mogoče oceniti).
Temodal is used for the treatment of specific forms of brain tumours: - in adults with newly-diagnosed glioblastoma multiforme. 
Zdravilo Temodal se uporablja za zdravljenje določenih vrst možganskih tumorjev: - pri odraslih z novo diagnosticiranim multiformnim glioblastomom.
Hypokalaemia, alkaline phosphatase increased 
hipokaliemija, zvišana vrednost alkalne fosfataze
If you forget to take Temodal 
Če ste pozabili vzeti zdravilo Temodal
Infections, herpes zoster, pharyngitis a, candidiasis oral 
okužbe, herpes zoster, faringitis a, oralna kandidiaza
Before each new treatment cycle, your blood will be tested to see if the Temodal dose needs to be adjusted. 
Pred vsakim ciklom zdravljenja bodo opravili krvne preiskave, s katerimi bodo ugotovili, ali je treba odmerek zdravila Temodal prilagoditi.
This led to hospitalisation and/or discontinuation of TMZ in 8 % and 4 %, respectively. 
Zaradi njiju je bila potrebna hospitalizacija in/ali prekinitev zdravljenja s TMZ pri 8 % oz. 4 % bolnikov.
If use during pregnancy must be considered, the patient should be apprised of the potential risk to the foetus. 
Če je uporaba v času nosečnosti nujna, morate bolnico opozoriti na možne nevarnosti zdravila za plod.
If you take more Temodal than you should If you accidentally take more Temodal capsules than you were told to, contact your doctor, pharmacist or nurse immediately. 
Če ste vzeli večji odmerek zdravila Temodal, kot bi smeli Če pomotoma vzamete preveč kapsul Temodal, se takoj posvetujte z zdravnikom, farmacevtom ali medicinsko sestro.
If you vomit frequently before or during treatment, ask your doctor about the best time to take Temodal until the vomiting is under control. 
Če pred zdravljenjem ali med njim pogosto bruhate, se posvetujte z zdravnikom o tem, kateri je najprimernejši čas za jemanje zdravila Temodal, dokler bruhanje ne bo pod nadzorom.
Nausea and vomiting are very commonly associated with TMZ. 
Navzea in bruhanje sta pogosto povezana z zdravljenjem s TMZ.
Data on time to worsening of neurological status favoured TMZ over procarbazine as did data on time to worsening of performance status (decrease to a KPS of < 70 or a decrease by at least 30 points). 
Izsledki glede časa do poslabšanja nevrološkega statusa so bili v prid TMZ v primerjavi s prokarbazinom, kar velja tudi za izsledke glede časa do poslabšanja stanja zmogljivosti bolnika po Karnofskyju (upad na KPS < 70 ali zmanjšanje za najmanj 30 točk).
Data on clinical efficacy in patients with glioblastoma multiforme (Karnofsky performance status [KPS]  70), progressive or recurrent after surgery and RT, were based on two clinical trials with oral TMZ. 
Podatki o klinični učinkovitosti zdravila pri bolnikih z multiformnim glioblastomom (indeks kliničnega stanja po Karnofskyju [KPS - »Karnofsky performance status«]  70), ki napreduje ali se je ponovil po kirurškem posegu in RT, temeljijo na dveh kliničnih preskušanjih s peroralno uporabo TMZ.
Co-administration with valproic acid was associated with a small but statistically significant decrease in clearance of TMZ. 
Sočasno jemanje z valprojsko kislino je bilo povezano z majhnim, a statistično pomembnim zmanjšanjem očistka TMZ.
C elimination is renal. 
C se izloča predvsem preko ledvic.
This may cause you to have increased bruising or bleeding, anaemia (a shortage of red blood cells), fever, and reduced resistance to infections. 
Posledice so lahko povečana nagnjenost k podplutbam ali krvavitvam, anemija (pomanjkanje eritrocitov), zvišana telesna temperatura in zmanjšana odpornost proti okužbam.
The reconstituted solution should not be used if discolouration or particulate matter is observed. 
Rekonstituirana raztopina se ne sme uporabiti, če opazite spremembo barve ali delce.
At the start of Cycle 2, the dose is escalated to 200 mg/m2 if the CTC non-haematological toxicity for Cycle 1 is Grade ≤ 2 (except for alopecia, nausea and vomiting), absolute neutrophil count (ANC) is ≥ 1.5 x 10 
Na začetku 2. cikla odmerek povečajte na 200 mg/m2, če je SMT za nehematološko toksičnost za 1. cikel stopnje ≤ 2 (z izjemo alopecije, slabosti in bruhanja), absolutno število nevtrofilcev (ANC) ≥ 1,5 x 10
- absolute neutrophil count (ANC) ≥ 1.5 x 10 
- absolutno število nevtrofilcev (ANC - Absolute Neutrophil Count) ≥ 1,5 x 10
Temodal will be given to you by your doctor in a drip into a vein (intravenous infusion), only over approximately 90 minutes. 
Zdravilo Temodal vam bo dal zdravnik s počasnim vtakanjem v veno (intravensko infundiranje), ki sme trajati približno 90 minut.
If you are a newly-diagnosed patient (glioblastoma multiforme) you may be receiving Temodal for 42 days in combination with radiotherapy. 
Če so vam bolezen (multiformni glioblastom) ugotovili na novo, boste morda zdravilo Temodal prejemali 42 dni v kombinaciji z radioterapijo.
Temodal contains lactose (a kind of sugar). 
Zdravilo Temodal vsebuje laktozo (vrsta sladkorja).
Your blood will be tested frequently during treatment to monitor the side effects of Temodal on your blood cells. 
Med zdravljenjem vam bodo pogosto pregledovali kri, da bodo lahko spremljali učinke zdravila Temodal na krvne celice.
- if you have low counts of red blood cells (anaemia), white blood cells and platelets, or blood clotting problems before starting the treatment, or if you develop them during treatment. 
- če imate majhno število eritrocitov (anemijo), levkocitov in trombocitov, če imate težave s strjevanjem krvi pred začetkom zdravljenja, ali če se takšne težave pojavijo med zdravljenjem.
Opportunistic infection (including PCP), sepsis meningoencephalitis herpetic 
oportunistične okužbe (vključno s PCP), sepsa herpetični meningoencefalitis
Store in a refrigerator (2 C - 8 C). 
Shranjujte v hladilniku (2 °C-8 °C).
The hazard ratio (HR) for overall survival was 1.59 (95 % CI for HR=1.33 -1.91) with a log-rank p < 0.0001 in favour of the TMZ arm. 
Količnik tveganja (KT) za skupno preživetje je bil 1,59 (95 % IZ za KT=1,33 -1,91) z logaritmičnim rangom p < 0,0001 v prid delu študije s TMZ.
Doses of 500, 750, 1,000, and 1,250 mg/m 
Pri bolnikih so klinično ovrednotili odmerke 500, 750, 1.000 in 1.250 mg/m
Adverse reactions reported during the two studies with the intravenous formulation (n=35) but not in studies using hard capsules, were infusion site reactions: pain, irritation, pruritus, warmth, swelling, and erythema, as well as haematoma. 
Neželene reakcije, o katerih so poročali v dveh študijah z intravensko formulacijo (n=35), ki pa se niso pojavile v študijah, v katerih so uporabljali trde kapsule, so bile reakcije na mestu infundiranja: bolečina, draženje, pruritus, občutek vročine, otekanje in eritem ter hematom.
Gamma-glutamyltransferase increased Injury, poisoning and procedural complications Common: 
zvišana vrednost gama-glutamiltransferaze Poškodbe, zastrupitve in zapleti pri posegih Pogosti:
6 position of guanine with additional alkylation also occurring at the N 
6, z dodatnim alkiliranjem na položaju N
a: TMZ dose levels are listed in Table 2. b: TMZ is to be discontinued if: 
SMT 4. stopnje a: Ravni odmerkov TMZ so podane v preglednici 2. b: TMZ morate ukiniti, če:
The addition of concomitant TMZ to RT, followed by TMZ monotherapy in the treatment of patients with newly-diagnosed glioblastoma multiforme demonstrated a statistically significant improvement in overall survival (OS) compared with RT alone (Figure 1). 
Pri dodatku sočasne terapije s TMZ k radioterapiji, ki ji sledi monoterapija s TMZ, med zdravljenjem bolnikov z novo diagnosticiranim multiformnim glioblastomom so ugotovili statistično značilno izboljšanje skupnega preživetja (OS) v primerjavi s samo RT (Slika 1).
Sachets are composed of linear low density polyethylene (innermost layer), aluminium and polyethylene terephthalate. 
Vrečke so iz linearnega polietilena nizke gostote (najbolj notranja plast), aluminija in polietilen terftalata.
Grade 3 or 4 thrombocytopenia and neutropenia occurred in 19 % and 17 % respectively, of patients treated for malignant glioma. 
Trombocitopenija in nevtropenija 3. in. 4. stopnje sta se pojavili pri 19 % in. 17 % bolnikov, zdravljenih zaradi malignega glioma.
Figure 1 Kaplan-Meier curves for overall survival (Intent to treat population) 
Slika 1 Kaplan-Meierjevi krivulji skupnega preživetja (populacija, ki so jo nameravali zdraviti)
The following information is intended for medical or health care professional use only: 
Naslednje informacije so namenjene samo zdravstvenemu osebju.
During the concomitant phase, your doctor will start Temodal at a dose of 75 mg/m2 (usual dose). 
Med fazo sočasnega zdravljenja vam bo zdravnik začel dajati zdravilo Temodal v odmerku 75 mg/m (običajni odmerek).
†, CMV infection, CMV reactivation, hepatitis B virus 
†, okužba s citomegalovirusom (CMV), reaktivacija CMV, virus hepatitisa B
Pharmacotherapeutic group: Antineoplastic agents - Other alkylating agents, ATC code: L01A X03 
Farmakoterapevtska skupina: Antineoplastična zdravila - drugi alkilirajoči citostatiki, oznaka ATC: L01A X03
Prolonged pancytopenia, aplastic anaemia pancytopenia, petechiae 
podaljšana pancitopenija, aplastična anemija pancitopenija, petehije
Temodal should only be prescribed by physicians experienced in the oncological treatment of brain tumours. 
Zdravilo Temodal smejo predpisati le zdravniki, ki imajo izkušnje z zdravljenjem možganskih tumorjev.
You will receive this dose every day for 42 days (up to 49 days) in combination with radiotherapy. 
Ta odmerek boste 42 dni (do 49 dni) prejemali vsak dan v kombinaciji z radioterapijo.
Patients who have experienced severe (Grade 3 or 4) vomiting in previous treatment cycles may require anti-emetic therapy. 
Pri bolnikih, ki so močno bruhali (stopnja 3 ali 4) v prejšnjih ciklih zdravljenja, je potrebno antiemetično zdravljenje.
You will take this dose every day for 42 days (up to 49 days) in combination with radiotherapy. 
Ta odmerek boste 42 dni (do 49 dni) jemali vsak dan v kombinaciji z radioterapijo.
Cushingoid 
cushingoidni sindrom
This medicinal product is for single use only. 
To zdravilo je le za enkratno uporabo.
Agitation, amnesia, depression, anxiety, confusion, insomnia 
vznemirjenost, amnezija, depresija, anksioznost, zmedenost, nespečnost
†, hepatic injury, hepatitis, cholestasis, hyperbilirubinemia 
†, poškodba jeter, hepatitis, holestaza, hiperbilirubinemija
Mean AUC (0  ) values for TMZ and MTIC were 25 µg•h/ml and 1,004 ng•h/ml, respectively. 
Srednja vrednost AUC (0  ) za TMZ je bila 25 µg•h/ml, za MTIK pa 1,004 ng•h/ml.
TMZ dose (mg/m 2/day) 
Odmerek TMZ (mg/m 2/dan)
A total of 573 patients were randomised to receive either TMZ + RT (n=287) or RT alone (n=286). 
Skupaj 573 bolnikov so randomizirali v dve skupini, od katerih je ena prejemala TMZ + RT (n=287), druga pa samo RT (n=286).
In some cases, it may be necessary to stop treatment with Temodal. 
V nekaterih primerih je treba zdravljenje z zdravilom Temodal prekiniti.
(≥ 1/100 to < 1/10); Uncommon (≥ 1/1,000 to < 1/100); Rare (≥1/10,000 to <1/1,000); Very rare (<1/10,000); Not known (cannot be estimated from the available data). 
Pogostnost je opredeljena na naslednji način: zelo pogosti ( 1/10); pogosti ( 1/100, < 1/10); občasni ( 1/1.000, < 1/100), redki (≥ 1/10.000 do < 1/1.000), zelo redki (< 1/10.000), neznana pogostnost (pogostnosti iz razpoložljivih podatkov ni mogoče oceniti).
Thus, prophylaxis against PCP is required for all patients receiving concomitant TMZ and RT for the 42-day regimen (with a maximum of 49 days) regardless of lymphocyte count. 
Profilaksa proti PCP je torej potrebna pri vseh bolnikih, ki sočasno prejemajo TMZ in RT v okviru 42-dnevne sheme zdravljenja (do največ 49 dni), ne glede na število limfocitov.
If Temodal comes into contact with skin or mucosa, it should be washed immediately and thoroughly with soap and water. 
Če pride zdravilo Temodal v stik s kožo ali sluznico, jo morate takoj in temeljito umiti z milom in vodo.
If Temodal 2.5 mg/ml comes into contact with skin or mucosa, it should be washed immediately and thoroughly with soap and water. 
Če zdravilo Temodal 2,5 mg/ml pride v stik s kožo ali sluznico, ga je treba takoj temeljito izprati z milom in vodo.
The Temodal dose may be adjusted, delayed or stopped depending on your blood counts and how you tolerate your medicine during each treatment cycle. 
Odmerek zdravila Temodal lahko prilagodijo, prestavijo ali zdravljenje prekinejo glede na vašo krvno sliko in na to, kako dobro prenašate zdravilo med vsakim ciklom zdravljenja.
In the noncomparative trial, the PFS at 6 months was 19 %, the median progression-free survival was 2.1 months, and the median overall survival 5.4 months. 
V neprimerjalnem preskušanju je bil PFS po 6 mesecih 19 %, mediana vrednost PFS 2,1 meseca in mediana vrednost celotnega preživetja 5,4 mesecev.
Behaviour disorder, emotional lability, hallucination, apathy 
vedenjske motnje, čustvena nestabilnost, halucinacije, apatija
The pump tubing should be attached to the bag, the tubing purged and then capped. 
Cevi črpalke je treba priključiti na vrečko, jo izprazniti in nato pokriti.
If you accidentally get some in your eyes or nose, flush the area with water. 
Če pride zdravilo Temodal po nesreči v stik z očmi ali nosom, to področje sperite z vodo.
In preclinical studies in rats and rabbits receiving 150 mg/m TMZ, teratogenicity and/or foetal toxicity were demonstrated (see section 5.3). 
Podatkov o nosečnicah ni. Predklinične študije na podganah in kuncih, ki so prejemali 150 mg/m TMZ, so pokazale teratogenost in/ali toksičnost za plod (glejte poglavje 5.3).
Myelodysplastic syndrome (MDS), secondary malignancies, including myeloid leukaemia 
mielodisplastični sindrom (MDS), sekundarni malignomi, vključno z mieloidno levkemijo
What Temodal looks like and contents of the pack 
Izgled zdravila Temodal in vsebina pakiranja
Temodal may cause permanent infertility. 
Zdravilo Temodal lahko povzroči trajno neplodnost.
†, interstitial pneumonitis/pneumonitis, pulmonary fibrosis, nasal congestion 
†, intersticijski pnevmonitis/pnevmonitis, pljučna fibroza, kongestija nosne sluznice
The resulting solution contains 2.5 mg/ml TMZ. 
Tako pridobljena raztopina vsebuje 2,5 mg/ml TMZ.
Dose levels include 100 mg/m 2, 150 mg/m 2, and 
Stopnje odmerka so 100 mg/m 2, 150 mg/m 2 in
CSF penetration was confirmed in one patient; CSF exposure based on AUC of TMZ was approximately 30 % of that in plasma, which is consistent with animal data. 
Izpostavljenost TMZ v CSF, določena na podlagi AUC za TMZ, je bila približno 30 % tiste v plazmi, kar je v skladu s podatki, ki so jih dobili pri živalih.
What Temodal is and what it is used for 
Kaj je zdravilo Temodal in za kaj ga uporabljamo
Adult and paediatric patients 3 years of age or older with recurrent or progressive malignant glioma: 
Odrasli in pediatrični bolniki, stari 3 leta ali več, s ponavljajočim se ali napredujočim malignim gliomom:
Men being treated with TMZ should be advised not to father a child up to 6 months after receiving the last dose and to seek advice on cryoconservation of sperm prior to treatment (see section 4.6). 
Moškim, ki se zdravijo s TMZ, je treba svetovati, naj ne zaplodijo otroka še šest mesecev po prejetem zadnjem odmerku in naj se pred zdravljenjem posvetujejo o možnostih shranjevanja zamrznjene sperme (glejte poglavje 4.6).
If you are pregnant, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before using this medicine. 
Če ste noseči, menite, da bi lahko bili noseči, ali načrtujete zanositev, se posvetujte z zdravnikom ali farmacevtom, preden uporabite to zdravilo.
In patients treated with TMZ in clinical trials, the most common adverse reactions were nausea, vomiting, constipation, anorexia, headache, fatigue, convulsions, and rash. 
Pri bolnikih, ki so se v kliničnih preizkušanjih zdravili s TMZ, so bili najpogostejši neželeni učinki navzea, bruhanje, zaprtje, anoreksija, glavobol, utrujenost, konvulzije in izpuščaji.
It is recommended to seek advice on conservation of sperm prior to treatment. 
Priporočamo, da se pred zdravljenjem pozanimate glede možnosti shranjevanja sperme.
After oral administration to adult patients, TMZ is absorbed rapidly, with peak concentrations reached as early as 20 minutes post-administration (mean time between 0.5 and 1.5 hours). 
Po peroralnem vnosu se pri odraslih zdravilo TMZ hitro absorbira in doseže največjo koncentracijo že v 20 minutah po zaužitju odmerka (srednja vrednost časa med 0,5 in 1,5 ure).
It is incompatible with dextrose solutions. 
Zdravilo je nekompatibilno z raztopino dekstroze.
If you are a newly-diagnosed patient, treatment will occur in two phases: - treatment together with radiotherapy (concomitant phase) first - followed by treatment with only Temodal (monotherapy phase). 
Če so vam bolezen diagnosticirali na novo, bo zdravljenje potekalo v dveh fazah: - najprej zdravljenje skupaj z radioterapijo (faza sočasnega zdravljenja), - ki ji sledi zdravljenje samo z zdravilom Temodal (faza samostojnega zdravljenja).
A complete blood count should be obtained on Day 22 (21 days after the first dose) or within 48 hours of that day, and weekly until ANC > 1.5 x 10 
Na 22. dan (21 dni po prvem odmerku) ali v roku 48 ur od navedenega dne, morate pregledati celotno krvno sliko in jo nato spremljati vsak teden, dokler ni ANC > 1,5 x 10
In a study of 288 subjects with newlydiagnosed glioblastoma multiforme, Grade 4 neutropenia occurred in 3 % of female vs 0 % of male subjects and Grade 4 thrombocytopenia in 1 % of female vs 0 % of male subjects in the first cycle of therapy. 
V študiji pri 288 preiskovancih z novo diagnosticiranim multiformnim glioblastomom se je v prvem ciklu terapije nevtropenija 4. stopnje pojavila pri 3 % žensk in 0 % moških, trombocitopenija 4. stopnje pa pri 1 % žensk in 0 % moških.
No data are available on the administration of TMZ in patients with severe hepatic impairment (Child's Class C) or with renal impairment. 
Podatki o uporabi TMZ pri bolnikih s hudo jetrno okvaro (razred C po Childu) ali ledvično okvaro, niso na voljo.
Paediatric patients had a higher AUC than adult patients; however, the maximum tolerated dose (MTD) was 1,000 mg/m2 per cycle both in children and in adults. 
Pri otrocih je bila vrednost AUC večja kot pri odraslih, medtem ko je bil največji odmerek, ki so ga bolniki še prenašali (MTD - »maximum tolerated dose«), pri obojih 1.000 mg/m na cikel.
A treatment cycle with Temodal lasts 28 days. 
Cikel zdravljenja z zdravilom Temodal traja 28 dni.
It is very important to check with your doctor or pharmacist if you are not sure. 
Zelo pomembno je, da se, če ste negotovi, posvetujete z zdravnikom ali farmacevtom.
The dose should be reduced or administration discontinued according to Table 3. 
Odmerek zmanjšajte ali zdravljenje ukinite, kot je opisano v tabeli 3.
†, herpes simplex, infection reactivation, wound infection, gastroenteritis Neoplasm benign, malignant, and unspecified Uncommon: 
†, herpes simplex, reaktivacija okužb, okužbe ran, gastroenteritis Benigne, maligne in neopredeljene novotvorbe
VIAL LABEL 
OZNAKA NA VIALI
Talk to your doctor, pharmacist or nurse before taking Temodal, - as you should be observed closely for the development of a serious form of chest infection called Pneumocystis jirovecii pneumonia (PCP). 
Pred začetkom jemanja zdravila Temodal se posvetujte z zdravnikom, farmacevtom ali medicinsko sestro: - ker vas mora zdravnik pozorno opazovati zaradi možnosti pojava resne oblike okužbe dihal, imenovane pljučnica zaradi okužbe s Pneumocystis jirovecii (PCP).
Very Common side effects (may affect more than 1 in 10 people) are: - loss of appetite, difficulty speaking, headache - vomiting, nausea, diarrhoea, constipation - rash, hair loss - tiredness 
Zelo pogosti neželeni učinki (pojavijo se lahko pri več kot 1 od 10 bolnikov) so: - izguba apetita, težave z govorom, glavobol - bruhanje, občutek siljenja na bruhanje, zaprtje - izpuščaj, izpadanje las - utrujenost
The appropriate dose of TMZ should be infused intravenously using a pump over a period of 90 minutes. 
Ustrezni odmerek TMZ je treba infundirati intravensko, s črpalko, infundiranje pa mora trajati 90 minut.
Liver enzymes elevation j, weight decreased, weight increased 
zvišane vrednosti jetrnih encimov j, zmanjšanje telesne mase, povečanje telesne mase
What you need to know before you use Temodal 
Kaj morate vedeti, preden boste uporabili zdravilo Temodal
Temodal 2.5 mg/ml powder for solution for infusion delivers equivalent TMZ dose and exposure to both TMZ and its active metabolite MTIC as the corresponding Temodal hard capsules (see section 5.2). 
Zdravilo Temodal 2,5 mg/ml prašek za raztopino za infundiranje dovaja enak odmerek TMZ in zagotavlja enako izpostavljenost TMZ in njegovem aktivnem presnovku, MTIK, kot ustrezne trde kapsule Temodal (glejte poglavje 5.2).
Toxic epidermal necrolysis, Stevens-Johnson syndrome, angioedema, erythema multiforme, erythroderma, skin exfoliation, photosensitivity reaction, urticaria, exanthema, dermatitis, sweating increased, pigmentation abnormal 
toksična epidermalna nekroliza, Stevens-Johnsonov sindrom, angioedem, multiformni eritem, luščenje kože, preobčutljivostne reakcije na svetlobo, urtikarija, eksantem, dermatitis, prekomerno potenje, nenormalna pigmentacija
Grade 3 or Grade 4 thrombocyte abnormalities, including thrombocytopenic events were observed in 14 % of the patients who received TMZ. 
Anomalije trombocitov 3. ali 4. stopnje, vključno s trombocitopeničnimi sopojavi, so opažali pri 14 % bolnikov, ki so prejeli TMZ.
Pneumonia, dyspnoea, sinusitis, bronchitis, coughing, upper respiratory infection 
pljučnica, dispneja, sinusitis, bronhitis, kašelj, okužba zgornjih dihal
Effective contraceptive precautions must be taken by both male and female patients who are taking Temodal (see also “Male fertility” below). 
Bolnice in bolniki, ki jemljejo zdravilo Temodal, morajo uporabljati učinkovito kontracepcijsko metodo (glejte tudi spodaj Plodnost pri moških).
Status epilepticus, hemiplegia, extrapyramidal disorder, parosmia, gait abnormality, hyperaesthesia, sensory disturbance, coordination abnormal 
status epilepticus, hemiplegija, ekstrapiramidne motnje, parozmija, nenormalna hoja, hiperestezija, senzorične motnje, motnje koordinacije
Powder for solution for infusion 1 vial 100 mg 
prašek za raztopino za infundiranje 1 viala 100 mg
Ataxia, balance impaired, cognition impaired, concentration impaired, consciousness decreased, dizziness, hypoesthesia, memory impaired, neurologic disorder, neuropathy d, paraesthesia, somnolence, speech disorder, taste perversion, tremor 
ataksija, motnje ravnotežja, motnje kognitivnih procesov, motnje koncentracije, motnje zavesti, omotica, hipestezija, motnje spomina, nevrološke motnje, nevropatija d, parestezija, somnolenca, motnje govora, motnje okušanja, tremor
capsule shell: 
ovojnice kapsul:
Temodal 5 mg hard capsules Temodal 20 mg hard capsules Temodal 100 mg hard capsules Temodal 140 mg hard capsules Temodal 180 mg hard capsules Temodal 250 mg hard capsules temozolomide 
Temodal 20 mg trde kapsule Temodal 100 mg trde kapsule Temodal 140 mg trde kapsule Temodal 180 mg trde kapsule Temodal 250 mg trde kapsule temozolomid (temozolomidum)
After reconstitution: 14 hours at 25 C, including infusion time. 
Po rekonstituciji: pri 25 C 14 ur, vključno s časom infundiranja.
No infusion site other than a vein is acceptable. 
Za infundiranje se ne sme uporabiti nobenega drugega mesta, razen vene.
Temodal is also available as a hard capsule formulation (oral use). 
Zdravilo Temodal je na voljo tudi v obliki trdih kapsul (za peroralno uporabo).